Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $834,374 (100.0% shares, 0.0% debt)

Holdings (57)

APLS APELLIS PHARMACEUTICALS INC 19.8%
Value ($000) $164,994 Shares 2,806,980 Est. Cost $47.59 Unrealized +33.9%
ALPINE IMMUNE SCIENCES INC 5.9%
Value ($000) $49,205 Shares 1,241,300 Est. Cost $11.89 Unrealized
DNTH DIANTHUS THERAPEUTICS INC 5.0%
Value ($000) $41,420 Shares 1,380,667 Est. Cost $17.99 Unrealized +20.8%
VERONA PHARMA PLC 4.6%
Value ($000) $38,117 Shares 2,369,000 Est. Cost $17.59 Unrealized
DYN DYNE THERAPEUTICS INC 4.2%
Value ($000) $35,287 Shares 1,242,945 Est. Cost $16.21 Unrealized +39.5%
AVBP ARRIVENT BIOPHARMA INC 4.2%
Value ($000) $34,717 Shares 1,943,836 Est. Cost $20.17 Unrealized 0.0%
INSM INSMED INC 3.7%
Value ($000) $30,928 Shares 1,140,000 Est. Cost $21.76 Unrealized +28.6%
CNTA CENTESSA PHARMACEUTICALS PLC 2.8%
Value ($000) $23,279 Shares 2,060,100 Est. Cost $7.11 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 2.7%
Value ($000) $22,603 Shares 1,093,503 Est. Cost $24.76 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 2.6%
Value ($000) $22,068 Shares 2,425,000 Est. Cost $7.10 Unrealized 0.0%
GPCR STRUCTURE THERAPEUTICS INC 2.6%
Value ($000) $21,713 Shares 506,604 Est. Cost $41.14 Unrealized
BBIO BRIDGEBIO PHARMA INC 2.6%
Value ($000) $21,335 Shares 690,000 Est. Cost $30.51 Unrealized +11.5%
MIND MEDICINE MINDMED INC 2.4%
Value ($000) $20,238 Shares 2,153,000 Est. Cost $9.40 Unrealized
PERSPECTIVE THERAPEUTICS INC 2.1%
Value ($000) $17,515 Shares 14,718,422 Est. Cost $1.19 Unrealized
CRBP CORBUS PHARMACEUTICALS HLDGS 1.9%
Value ($000) $15,892 Shares 405,000 Est. Cost $24.66 Unrealized 0.0%
PRAX PRAXIS PRECISION MEDICINES I 1.9%
Value ($000) $15,865 Shares 260,000 Est. Cost $44.86 Unrealized 0.0%
TNYA TENAYA THERAPEUTICS INC 1.8%
Value ($000) $14,926 Shares 2,854,000 Est. Cost $4.78 Unrealized 0.0%
JSPR JASPER THERAPEUTICS INC 1.8%
Value ($000) $14,704 Shares 500,811 Est. Cost $17.76 Unrealized 0.0%
ANNX ANNEXON INC 1.8%
Value ($000) $14,699 Shares 2,050,000 Est. Cost $4.77 Unrealized +8.8%
CYTK CYTOKINETICS INC 1.6%
Value ($000) $13,601 Shares 194,000 Est. Cost $52.75 Unrealized +46.6%
AEROVATE THERAPEUTICS INC 1.4%
Value ($000) $11,937 Shares 403,685 Est. Cost $29.30 Unrealized
APLS APELLIS PHARMACEUTICALS INC 1.4%
Value ($000) $11,756 Shares 200,000 Est. Cost $47.59 Unrealized +33.9%
VRDN VIRIDIAN THERAPEUTICS INC 1.3%
Value ($000) $10,856 Shares 620,000 Est. Cost $24.88 Unrealized -22.1%
GOSS GOSSAMER BIO INC 1.3%
Value ($000) $10,842 Shares 9,187,883 Est. Cost $2.93 Unrealized -62.4%
NAMS NEWAMSTERDAM PHARMA COMPANY 1.2%
Value ($000) $9,649 Shares 408,000 Est. Cost $20.30 Unrealized 0.0%
GLYCOMIMETICS INC 1.1%
Value ($000) $9,000 Shares 3,000,000 Est. Cost $1.26 Unrealized
IMVT IMMUNOVANT INC 1.1%
Value ($000) $8,830 Shares 273,289 Est. Cost $36.80 Unrealized -0.9%
TSHA TAYSHA GENE THERAPIES INC 1.0%
Value ($000) $8,696 Shares 3,030,000 Est. Cost $2.08 Unrealized 0.0%
AKERO THERAPEUTICS INC 1.0%
Value ($000) $8,588 Shares 340,000 Est. Cost $25.26 Unrealized
VTYX VENTYX BIOSCIENCES INC 1.0%
Value ($000) $8,256 Shares 1,501,114 Est. Cost $4.57 Unrealized 0.0%
CYBIN INC 0.9%
Value ($000) $7,693 Shares 18,604,650 Est. Cost $0.41 Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 0.9%
Value ($000) $7,150 Shares 250,000 Est. Cost $31.99 Unrealized 0.0%
MLYS MINERALYS THERAPEUTICS INC 0.9%
Value ($000) $7,101 Shares 550,000 Est. Cost $12.35 Unrealized 0.0%
SLN SILENCE THERAPEUTICS PLC 0.8%
Value ($000) $6,804 Shares 315,000 Est. Cost $21.60 Unrealized
PEPG PEPGEN INC 0.7%
Value ($000) $5,529 Shares 376,117 Est. Cost $11.81 Unrealized 0.0%
VINCERX PHARMA INC 0.6%
Value ($000) $5,060 Shares 1,000,000 Est. Cost $5.06 Unrealized
NUVB NUVATION BIO INC 0.6%
Value ($000) $5,005 Shares 1,374,870 Est. Cost $1.46 Unrealized +31.6%
PHAT PHATHOM PHARMACEUTICALS INC 0.6%
Value ($000) $4,832 Shares 455,000 Est. Cost $8.51 Unrealized -0.2%
MERSANA THERAPEUTICS INC 0.5%
Value ($000) $4,480 Shares 1,000,000 Est. Cost $4.48 Unrealized
TERN TERNS PHARMACEUTICALS INC 0.5%
Value ($000) $4,100 Shares 625,000 Est. Cost $6.53 Unrealized 0.0%
FATE FATE THERAPEUTICS INC 0.5%
Value ($000) $3,823 Shares 520,800 Est. Cost $6.19 Unrealized 0.0%
RENEO PHARMACEUTICALS INC 0.4%
Value ($000) $3,735 Shares 2,250,000 Est. Cost $6.46 Unrealized
ANAB ANAPTYSBIO INC 0.4%
Value ($000) $3,716 Shares 165,000 Est. Cost $19.00 Unrealized +24.6%
SANA SANA BIOTECHNOLOGY INC 0.4%
Value ($000) $3,608 Shares 360,800 Est. Cost $7.49 Unrealized 0.0%
ANTX AN2 THERAPEUTICS INC 0.4%
Value ($000) $3,585 Shares 1,103,000 Est. Cost $9.08 Unrealized +19.9%
ALLO ALLOGENE THERAPEUTICS INC 0.4%
Value ($000) $3,218 Shares 720,000 Est. Cost $4.17 Unrealized 0.0%
ALLOVIR INC 0.4%
Value ($000) $3,171 Shares 4,200,000 Est. Cost $0.75 Unrealized
VERU INC 0.3%
Value ($000) $2,660 Shares 3,800,000 Est. Cost $0.72 Unrealized
RAPT THERAPEUTICS INC 0.3%
Value ($000) $2,622 Shares 292,000 Est. Cost $24.85 Unrealized
NKTX NKARTA INC 0.3%
Value ($000) $2,594 Shares 240,000 Est. Cost $10.40 Unrealized 0.0%
BBOT HELIX ACQUISITION CORP II 0.3%
Value ($000) $2,588 Shares 250,000 Est. Cost $10.35 Unrealized 0.0%
POSEIDA THERAPEUTICS INC 0.3%
Value ($000) $2,348 Shares 736,000 Est. Cost $3.19 Unrealized
IPSC CENTURY THERAPEUTICS INC 0.3%
Value ($000) $2,257 Shares 540,000 Est. Cost $4.23 Unrealized 0.0%
ADICET BIO INC 0.2%
Value ($000) $1,804 Shares 767,799 Est. Cost $2.35 Unrealized
ATYR ATYR PHARMA INC 0.2%
Value ($000) $1,365 Shares 700,000 Est. Cost $1.74 Unrealized 0.0%
AUTL AUTOLUS THERAPEUTICS PLC 0.1%
Value ($000) $1,123 Shares 176,000 Est. Cost $6.38 Unrealized
CABA CABALETTA BIO INC 0.1%
Value ($000) $887 Shares 52,000 Est. Cost $21.46 Unrealized 0.0%